Sarabvijay Singh is the founder of ValueRx and brings 14 years of experience in the pharmaceutical and biotech industry, having started his career at GlaxoSmithKline. For over a decade, he has worked within the pharmaceutical consulting industry and progressed to senior leadership roles, most recently at Oliver Wyman. His expertise lies in building global pricing and market access strategies for novel therapies, as well as developing commercial and market access capabilities in pharmaceutical organisations. He has worked with 8 of the top 10 global pharmaceutical organisations and consulted on nearly 100 projects.